|
End-of-day quote
Other OTC
|
||
| - USD | - |
|
| 21/05 | BioRegenx, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 16/04 | BioRegenx, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 97.16K 88.2K 81.47K 73.5K 139K 9.08M 144K 982K 388K 4.9M 365K 357K 15.48M | P/E 2024 |
-0.37x | P/E 2025 | -8.02x |
|---|---|---|---|---|---|
| Enterprise Value | 2.24M 2.04M 1.88M 1.7M 3.2M 209M 3.33M 22.66M 8.96M 113M 8.41M 8.24M 357M | EV / Sales 2024 |
4.58x | EV / Sales 2025 | 7.85x |
| Free-Float |
-
| Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
William Resides
CEO | Chief Executive Officer | 57 | 08/03/2024 |
Gary Hennerberg
SEC | Corporate Secretary | 69 | 08/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Powers
BRD | Director/Board Member | 71 | 01/01/2012 |
William Resides
BRD | Director/Board Member | 57 | 08/03/2024 |
Suzanne Bird
BRD | Director/Board Member | 61 | 08/03/2024 |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.34M 2.12M 1.96M 1.77M 3.34M 219M 3.47M 23.65M 9.35M 118M 8.78M 8.59M 373M | 1.85M 1.68M 1.56M 1.4M 2.65M 173M 2.75M 18.74M 7.41M 93.5M 6.96M 6.81M 295M |
| Net income | -23.05M -20.93M -19.33M -17.44M -32.93M -2.15B -34.19M -233M -92.14M -1.16B -86.5M -84.68M -3.67B | -1.54M -1.4M -1.29M -1.17M -2.2M -144M -2.29M -15.6M -6.17M -77.82M -5.79M -5.67M -246M |
| Net Debt | 2.11M 1.91M 1.77M 1.59M 3.01M 197M 3.12M 21.28M 8.42M 106M 7.9M 7.73M 335M | 2.15M 1.95M 1.8M 1.62M 3.06M 200M 3.18M 21.68M 8.57M 108M 8.05M 7.88M 342M |
Employees
-
Sector
-
Select your edition
All financial news and data tailored to specific country editions
















